nodes	percent_of_prediction	percent_of_DWPC	metapath
Amitriptyline—HTR1B—attention deficit hyperactivity disorder	0.153	0.212	CbGaD
Amitriptyline—DRD3—attention deficit hyperactivity disorder	0.148	0.206	CbGaD
Amitriptyline—ADRA2A—attention deficit hyperactivity disorder	0.135	0.187	CbGaD
Amitriptyline—SLC6A4—attention deficit hyperactivity disorder	0.103	0.143	CbGaD
Amitriptyline—DRD2—attention deficit hyperactivity disorder	0.103	0.142	CbGaD
Amitriptyline—HTR2A—attention deficit hyperactivity disorder	0.0793	0.11	CbGaD
Amitriptyline—SLC6A2—locus ceruleus—attention deficit hyperactivity disorder	0.00352	0.0365	CbGeAlD
Amitriptyline—HTR7—locus ceruleus—attention deficit hyperactivity disorder	0.00339	0.0352	CbGeAlD
Amitriptyline—ORM1—saliva—attention deficit hyperactivity disorder	0.00243	0.0253	CbGeAlD
Amitriptyline—HTR2A—locus ceruleus—attention deficit hyperactivity disorder	0.00211	0.022	CbGeAlD
Amitriptyline—SLC6A2—autonomic nervous system—attention deficit hyperactivity disorder	0.00187	0.0194	CbGeAlD
Amitriptyline—NTRK2—forebrain—attention deficit hyperactivity disorder	0.00184	0.0191	CbGeAlD
Amitriptyline—HTR7—autonomic nervous system—attention deficit hyperactivity disorder	0.0018	0.0187	CbGeAlD
Amitriptyline—NTRK1—midbrain—attention deficit hyperactivity disorder	0.00159	0.0165	CbGeAlD
Amitriptyline—NTRK2—cardiovascular system—attention deficit hyperactivity disorder	0.00156	0.0162	CbGeAlD
Amitriptyline—KCNQ3—forebrain—attention deficit hyperactivity disorder	0.00139	0.0145	CbGeAlD
Amitriptyline—KCNQ2—forebrain—attention deficit hyperactivity disorder	0.00128	0.0133	CbGeAlD
Amitriptyline—KCND2—forebrain—attention deficit hyperactivity disorder	0.00121	0.0126	CbGeAlD
Amitriptyline—NTRK2—midbrain—attention deficit hyperactivity disorder	0.00121	0.0126	CbGeAlD
Amitriptyline—KCNQ3—cardiovascular system—attention deficit hyperactivity disorder	0.00118	0.0122	CbGeAlD
Amitriptyline—HTR2A—autonomic nervous system—attention deficit hyperactivity disorder	0.00112	0.0117	CbGeAlD
Amitriptyline—KCNA1—forebrain—attention deficit hyperactivity disorder	0.00106	0.0111	CbGeAlD
Amitriptyline—KCND3—forebrain—attention deficit hyperactivity disorder	0.00106	0.011	CbGeAlD
Amitriptyline—KCND2—cardiovascular system—attention deficit hyperactivity disorder	0.00103	0.0107	CbGeAlD
Amitriptyline—NTRK2—nervous system—attention deficit hyperactivity disorder	0.000999	0.0104	CbGeAlD
Amitriptyline—NTRK2—central nervous system—attention deficit hyperactivity disorder	0.000961	0.00998	CbGeAlD
Amitriptyline—NTRK2—cerebellum—attention deficit hyperactivity disorder	0.00094	0.00976	CbGeAlD
Amitriptyline—KCNQ3—midbrain—attention deficit hyperactivity disorder	0.000921	0.00956	CbGeAlD
Amitriptyline—HTR6—forebrain—attention deficit hyperactivity disorder	0.000903	0.00938	CbGeAlD
Amitriptyline—KCND3—cardiovascular system—attention deficit hyperactivity disorder	0.000896	0.0093	CbGeAlD
Amitriptyline—OPRD1—forebrain—attention deficit hyperactivity disorder	0.000872	0.00906	CbGeAlD
Amitriptyline—OPRK1—forebrain—attention deficit hyperactivity disorder	0.000836	0.00868	CbGeAlD
Amitriptyline—KCND2—midbrain—attention deficit hyperactivity disorder	0.000802	0.00833	CbGeAlD
Amitriptyline—NTRK2—brain—attention deficit hyperactivity disorder	0.000763	0.00793	CbGeAlD
Amitriptyline—KCNQ3—nervous system—attention deficit hyperactivity disorder	0.000757	0.00786	CbGeAlD
Amitriptyline—KCNQ3—central nervous system—attention deficit hyperactivity disorder	0.000729	0.00757	CbGeAlD
Amitriptyline—KCNQ3—cerebellum—attention deficit hyperactivity disorder	0.000712	0.0074	CbGeAlD
Amitriptyline—ADRA1D—forebrain—attention deficit hyperactivity disorder	0.000705	0.00732	CbGeAlD
Amitriptyline—KCNA1—midbrain—attention deficit hyperactivity disorder	0.000703	0.0073	CbGeAlD
Amitriptyline—KCND3—midbrain—attention deficit hyperactivity disorder	0.000699	0.00726	CbGeAlD
Amitriptyline—HRH2—cardiovascular system—attention deficit hyperactivity disorder	0.000698	0.00725	CbGeAlD
Amitriptyline—KCNQ2—nervous system—attention deficit hyperactivity disorder	0.000696	0.00723	CbGeAlD
Amitriptyline—KCNQ2—central nervous system—attention deficit hyperactivity disorder	0.000671	0.00696	CbGeAlD
Amitriptyline—KCND2—nervous system—attention deficit hyperactivity disorder	0.00066	0.00685	CbGeAlD
Amitriptyline—KCNQ2—cerebellum—attention deficit hyperactivity disorder	0.000655	0.00681	CbGeAlD
Amitriptyline—KCND2—central nervous system—attention deficit hyperactivity disorder	0.000635	0.00659	CbGeAlD
Amitriptyline—KCND2—cerebellum—attention deficit hyperactivity disorder	0.000621	0.00645	CbGeAlD
Amitriptyline—OPRM1—forebrain—attention deficit hyperactivity disorder	0.000595	0.00618	CbGeAlD
Amitriptyline—KCNQ3—brain—attention deficit hyperactivity disorder	0.000578	0.00601	CbGeAlD
Amitriptyline—KCNA1—nervous system—attention deficit hyperactivity disorder	0.000578	0.006	CbGeAlD
Amitriptyline—KCND3—nervous system—attention deficit hyperactivity disorder	0.000575	0.00597	CbGeAlD
Amitriptyline—KCNA1—central nervous system—attention deficit hyperactivity disorder	0.000556	0.00578	CbGeAlD
Amitriptyline—KCND3—central nervous system—attention deficit hyperactivity disorder	0.000554	0.00575	CbGeAlD
Amitriptyline—CHRM4—nervous system—attention deficit hyperactivity disorder	0.000548	0.00569	CbGeAlD
Amitriptyline—HTR1B—forebrain—attention deficit hyperactivity disorder	0.000544	0.00565	CbGeAlD
Amitriptyline—KCNA1—cerebellum—attention deficit hyperactivity disorder	0.000544	0.00565	CbGeAlD
Amitriptyline—CHRM2—forebrain—attention deficit hyperactivity disorder	0.000541	0.00562	CbGeAlD
Amitriptyline—KCND3—cerebellum—attention deficit hyperactivity disorder	0.000541	0.00562	CbGeAlD
Amitriptyline—KCNQ2—brain—attention deficit hyperactivity disorder	0.000532	0.00553	CbGeAlD
Amitriptyline—CHRM4—central nervous system—attention deficit hyperactivity disorder	0.000527	0.00548	CbGeAlD
Amitriptyline—HTR1D—forebrain—attention deficit hyperactivity disorder	0.000527	0.00547	CbGeAlD
Amitriptyline—HTR2C—forebrain—attention deficit hyperactivity disorder	0.000522	0.00542	CbGeAlD
Amitriptyline—DRD3—nervous system—attention deficit hyperactivity disorder	0.000509	0.00529	CbGeAlD
Amitriptyline—KCND2—brain—attention deficit hyperactivity disorder	0.000504	0.00524	CbGeAlD
Amitriptyline—SLC6A4—forebrain—attention deficit hyperactivity disorder	0.000495	0.00514	CbGeAlD
Amitriptyline—CHRM1—forebrain—attention deficit hyperactivity disorder	0.000493	0.00512	CbGeAlD
Amitriptyline—DRD3—central nervous system—attention deficit hyperactivity disorder	0.00049	0.00509	CbGeAlD
Amitriptyline—HTR6—nervous system—attention deficit hyperactivity disorder	0.00049	0.00509	CbGeAlD
Amitriptyline—OPRD1—nervous system—attention deficit hyperactivity disorder	0.000473	0.00492	CbGeAlD
Amitriptyline—HTR6—central nervous system—attention deficit hyperactivity disorder	0.000472	0.0049	CbGeAlD
Amitriptyline—HTR1B—cardiovascular system—attention deficit hyperactivity disorder	0.00046	0.00478	CbGeAlD
Amitriptyline—CHRM2—cardiovascular system—attention deficit hyperactivity disorder	0.000458	0.00475	CbGeAlD
Amitriptyline—OPRD1—central nervous system—attention deficit hyperactivity disorder	0.000456	0.00473	CbGeAlD
Amitriptyline—OPRK1—nervous system—attention deficit hyperactivity disorder	0.000454	0.00471	CbGeAlD
Amitriptyline—HRH2—nervous system—attention deficit hyperactivity disorder	0.000448	0.00465	CbGeAlD
Amitriptyline—HTR1D—cardiovascular system—attention deficit hyperactivity disorder	0.000446	0.00463	CbGeAlD
Amitriptyline—KCNA1—brain—attention deficit hyperactivity disorder	0.000442	0.00459	CbGeAlD
Amitriptyline—CHRM3—forebrain—attention deficit hyperactivity disorder	0.000441	0.00458	CbGeAlD
Amitriptyline—KCND3—brain—attention deficit hyperactivity disorder	0.00044	0.00456	CbGeAlD
Amitriptyline—HTR1A—forebrain—attention deficit hyperactivity disorder	0.000439	0.00456	CbGeAlD
Amitriptyline—OPRK1—central nervous system—attention deficit hyperactivity disorder	0.000437	0.00454	CbGeAlD
Amitriptyline—SLC6A2—forebrain—attention deficit hyperactivity disorder	0.000436	0.00452	CbGeAlD
Amitriptyline—HRH2—central nervous system—attention deficit hyperactivity disorder	0.000431	0.00448	CbGeAlD
Amitriptyline—CHRM5—nervous system—attention deficit hyperactivity disorder	0.000428	0.00445	CbGeAlD
Amitriptyline—OPRK1—cerebellum—attention deficit hyperactivity disorder	0.000427	0.00444	CbGeAlD
Amitriptyline—HTR7—forebrain—attention deficit hyperactivity disorder	0.00042	0.00436	CbGeAlD
Amitriptyline—CHRM4—brain—attention deficit hyperactivity disorder	0.000419	0.00435	CbGeAlD
Amitriptyline—CHRM1—cardiovascular system—attention deficit hyperactivity disorder	0.000417	0.00433	CbGeAlD
Amitriptyline—CHRM5—central nervous system—attention deficit hyperactivity disorder	0.000412	0.00428	CbGeAlD
Amitriptyline—ADRA1A—forebrain—attention deficit hyperactivity disorder	0.000405	0.0042	CbGeAlD
Amitriptyline—DRD2—forebrain—attention deficit hyperactivity disorder	0.000397	0.00412	CbGeAlD
Amitriptyline—OPRM1—midbrain—attention deficit hyperactivity disorder	0.000393	0.00408	CbGeAlD
Amitriptyline—ADRA1B—nervous system—attention deficit hyperactivity disorder	0.000391	0.00406	CbGeAlD
Amitriptyline—DRD3—brain—attention deficit hyperactivity disorder	0.000389	0.00404	CbGeAlD
Amitriptyline—ADRA1D—nervous system—attention deficit hyperactivity disorder	0.000383	0.00397	CbGeAlD
Amitriptyline—ADRA1B—central nervous system—attention deficit hyperactivity disorder	0.000377	0.00391	CbGeAlD
Amitriptyline—HTR6—brain—attention deficit hyperactivity disorder	0.000375	0.00389	CbGeAlD
Amitriptyline—HTR1A—cardiovascular system—attention deficit hyperactivity disorder	0.000371	0.00386	CbGeAlD
Amitriptyline—ADRA1D—central nervous system—attention deficit hyperactivity disorder	0.000368	0.00383	CbGeAlD
Amitriptyline—OPRD1—brain—attention deficit hyperactivity disorder	0.000362	0.00376	CbGeAlD
Amitriptyline—HTR1B—midbrain—attention deficit hyperactivity disorder	0.000359	0.00373	CbGeAlD
Amitriptyline—HTR7—cardiovascular system—attention deficit hyperactivity disorder	0.000355	0.00369	CbGeAlD
Amitriptyline—Mianserin—ADRA2C—attention deficit hyperactivity disorder	0.000353	0.0574	CrCbGaD
Amitriptyline—HTR1D—midbrain—attention deficit hyperactivity disorder	0.000348	0.00361	CbGeAlD
Amitriptyline—OPRK1—brain—attention deficit hyperactivity disorder	0.000347	0.0036	CbGeAlD
Amitriptyline—HTR2C—midbrain—attention deficit hyperactivity disorder	0.000345	0.00358	CbGeAlD
Amitriptyline—HRH2—brain—attention deficit hyperactivity disorder	0.000343	0.00356	CbGeAlD
Amitriptyline—ADRA1A—cardiovascular system—attention deficit hyperactivity disorder	0.000342	0.00356	CbGeAlD
Amitriptyline—CHRM5—brain—attention deficit hyperactivity disorder	0.000327	0.0034	CbGeAlD
Amitriptyline—SLC6A4—midbrain—attention deficit hyperactivity disorder	0.000327	0.00339	CbGeAlD
Amitriptyline—SIGMAR1—midbrain—attention deficit hyperactivity disorder	0.000324	0.00337	CbGeAlD
Amitriptyline—OPRM1—nervous system—attention deficit hyperactivity disorder	0.000323	0.00335	CbGeAlD
Amitriptyline—ORM1—nervous system—attention deficit hyperactivity disorder	0.000315	0.00327	CbGeAlD
Amitriptyline—HRH1—forebrain—attention deficit hyperactivity disorder	0.000313	0.00325	CbGeAlD
Amitriptyline—OPRM1—central nervous system—attention deficit hyperactivity disorder	0.000311	0.00323	CbGeAlD
Amitriptyline—ADRA2A—forebrain—attention deficit hyperactivity disorder	0.000308	0.0032	CbGeAlD
Amitriptyline—ORM1—central nervous system—attention deficit hyperactivity disorder	0.000303	0.00315	CbGeAlD
Amitriptyline—ADRA1B—brain—attention deficit hyperactivity disorder	0.000299	0.00311	CbGeAlD
Amitriptyline—HTR1B—nervous system—attention deficit hyperactivity disorder	0.000295	0.00307	CbGeAlD
Amitriptyline—CHRM2—nervous system—attention deficit hyperactivity disorder	0.000294	0.00305	CbGeAlD
Amitriptyline—ADRA1D—brain—attention deficit hyperactivity disorder	0.000293	0.00304	CbGeAlD
Amitriptyline—HTR1A—midbrain—attention deficit hyperactivity disorder	0.00029	0.00301	CbGeAlD
Amitriptyline—HTR1D—nervous system—attention deficit hyperactivity disorder	0.000286	0.00297	CbGeAlD
Amitriptyline—HTR1B—central nervous system—attention deficit hyperactivity disorder	0.000284	0.00295	CbGeAlD
Amitriptyline—Doxepin—ADRA2C—attention deficit hyperactivity disorder	0.000283	0.046	CrCbGaD
Amitriptyline—HTR2C—nervous system—attention deficit hyperactivity disorder	0.000283	0.00294	CbGeAlD
Amitriptyline—CHRM2—central nervous system—attention deficit hyperactivity disorder	0.000283	0.00294	CbGeAlD
Amitriptyline—HTR7—midbrain—attention deficit hyperactivity disorder	0.000277	0.00288	CbGeAlD
Amitriptyline—HTR1D—central nervous system—attention deficit hyperactivity disorder	0.000275	0.00286	CbGeAlD
Amitriptyline—HTR2C—central nervous system—attention deficit hyperactivity disorder	0.000273	0.00283	CbGeAlD
Amitriptyline—CYP2B6—cardiovascular system—attention deficit hyperactivity disorder	0.000271	0.00282	CbGeAlD
Amitriptyline—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.000269	0.00279	CbGeAlD
Amitriptyline—SLC6A4—nervous system—attention deficit hyperactivity disorder	0.000269	0.00279	CbGeAlD
Amitriptyline—CHRM1—nervous system—attention deficit hyperactivity disorder	0.000268	0.00278	CbGeAlD
Amitriptyline—DRD2—midbrain—attention deficit hyperactivity disorder	0.000262	0.00272	CbGeAlD
Amitriptyline—HTR2A—forebrain—attention deficit hyperactivity disorder	0.000262	0.00272	CbGeAlD
Amitriptyline—Epinastine—ADRA2A—attention deficit hyperactivity disorder	0.000261	0.0423	CrCbGaD
Amitriptyline—SLC6A4—central nervous system—attention deficit hyperactivity disorder	0.000259	0.00268	CbGeAlD
Amitriptyline—CHRM1—central nervous system—attention deficit hyperactivity disorder	0.000258	0.00267	CbGeAlD
Amitriptyline—CYP2E1—cardiovascular system—attention deficit hyperactivity disorder	0.000255	0.00264	CbGeAlD
Amitriptyline—SIGMAR1—cerebellum—attention deficit hyperactivity disorder	0.000251	0.00261	CbGeAlD
Amitriptyline—OPRM1—brain—attention deficit hyperactivity disorder	0.000247	0.00256	CbGeAlD
Amitriptyline—CHRM3—nervous system—attention deficit hyperactivity disorder	0.000239	0.00249	CbGeAlD
Amitriptyline—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.000238	0.00248	CbGeAlD
Amitriptyline—HTR1A—nervous system—attention deficit hyperactivity disorder	0.000238	0.00248	CbGeAlD
Amitriptyline—SLC6A2—nervous system—attention deficit hyperactivity disorder	0.000236	0.00246	CbGeAlD
Amitriptyline—CHRM3—central nervous system—attention deficit hyperactivity disorder	0.00023	0.00239	CbGeAlD
Amitriptyline—HTR1A—central nervous system—attention deficit hyperactivity disorder	0.00023	0.00238	CbGeAlD
Amitriptyline—HTR7—nervous system—attention deficit hyperactivity disorder	0.000228	0.00237	CbGeAlD
Amitriptyline—SLC6A2—central nervous system—attention deficit hyperactivity disorder	0.000228	0.00236	CbGeAlD
Amitriptyline—HTR1B—brain—attention deficit hyperactivity disorder	0.000226	0.00235	CbGeAlD
Amitriptyline—CHRM2—brain—attention deficit hyperactivity disorder	0.000225	0.00233	CbGeAlD
Amitriptyline—HTR1A—cerebellum—attention deficit hyperactivity disorder	0.000224	0.00233	CbGeAlD
Amitriptyline—HTR2A—cardiovascular system—attention deficit hyperactivity disorder	0.000221	0.0023	CbGeAlD
Amitriptyline—ADRA1A—nervous system—attention deficit hyperactivity disorder	0.00022	0.00228	CbGeAlD
Amitriptyline—HTR7—central nervous system—attention deficit hyperactivity disorder	0.000219	0.00228	CbGeAlD
Amitriptyline—HTR1D—brain—attention deficit hyperactivity disorder	0.000219	0.00227	CbGeAlD
Amitriptyline—HTR2C—brain—attention deficit hyperactivity disorder	0.000217	0.00225	CbGeAlD
Amitriptyline—DRD2—nervous system—attention deficit hyperactivity disorder	0.000215	0.00224	CbGeAlD
Amitriptyline—HTR7—cerebellum—attention deficit hyperactivity disorder	0.000214	0.00223	CbGeAlD
Amitriptyline—ADRA1A—central nervous system—attention deficit hyperactivity disorder	0.000212	0.0022	CbGeAlD
Amitriptyline—ALB—brain—attention deficit hyperactivity disorder	0.000211	0.00219	CbGeAlD
Amitriptyline—DRD2—central nervous system—attention deficit hyperactivity disorder	0.000207	0.00215	CbGeAlD
Amitriptyline—ADRA1A—cerebellum—attention deficit hyperactivity disorder	0.000207	0.00215	CbGeAlD
Amitriptyline—SLC6A4—brain—attention deficit hyperactivity disorder	0.000205	0.00213	CbGeAlD
Amitriptyline—CHRM1—brain—attention deficit hyperactivity disorder	0.000204	0.00212	CbGeAlD
Amitriptyline—SIGMAR1—brain—attention deficit hyperactivity disorder	0.000204	0.00212	CbGeAlD
Amitriptyline—ADRA2A—midbrain—attention deficit hyperactivity disorder	0.000203	0.00211	CbGeAlD
Amitriptyline—DRD2—cerebellum—attention deficit hyperactivity disorder	0.000203	0.00211	CbGeAlD
Amitriptyline—Thiothixene—DRD1—attention deficit hyperactivity disorder	0.000188	0.0305	CrCbGaD
Amitriptyline—CHRM3—brain—attention deficit hyperactivity disorder	0.000183	0.0019	CbGeAlD
Amitriptyline—HTR1A—brain—attention deficit hyperactivity disorder	0.000182	0.00189	CbGeAlD
Amitriptyline—SLC6A2—brain—attention deficit hyperactivity disorder	0.000181	0.00188	CbGeAlD
Amitriptyline—Thiothixene—ADRA2A—attention deficit hyperactivity disorder	0.000174	0.0283	CrCbGaD
Amitriptyline—CYP2B6—nervous system—attention deficit hyperactivity disorder	0.000174	0.00181	CbGeAlD
Amitriptyline—HTR7—brain—attention deficit hyperactivity disorder	0.000174	0.00181	CbGeAlD
Amitriptyline—HTR2A—midbrain—attention deficit hyperactivity disorder	0.000173	0.00179	CbGeAlD
Amitriptyline—ABCB1—forebrain—attention deficit hyperactivity disorder	0.000172	0.00178	CbGeAlD
Amitriptyline—HRH1—nervous system—attention deficit hyperactivity disorder	0.00017	0.00177	CbGeAlD
Amitriptyline—ADRA1A—brain—attention deficit hyperactivity disorder	0.000168	0.00174	CbGeAlD
Amitriptyline—CYP2B6—central nervous system—attention deficit hyperactivity disorder	0.000168	0.00174	CbGeAlD
Amitriptyline—ADRA2A—nervous system—attention deficit hyperactivity disorder	0.000167	0.00174	CbGeAlD
Amitriptyline—Mianserin—DRD3—attention deficit hyperactivity disorder	0.000165	0.0269	CrCbGaD
Amitriptyline—DRD2—brain—attention deficit hyperactivity disorder	0.000165	0.00171	CbGeAlD
Amitriptyline—HRH1—central nervous system—attention deficit hyperactivity disorder	0.000164	0.0017	CbGeAlD
Amitriptyline—CYP2E1—nervous system—attention deficit hyperactivity disorder	0.000163	0.0017	CbGeAlD
Amitriptyline—ADRA2A—central nervous system—attention deficit hyperactivity disorder	0.000161	0.00167	CbGeAlD
Amitriptyline—CYP2E1—central nervous system—attention deficit hyperactivity disorder	0.000157	0.00163	CbGeAlD
Amitriptyline—ADRA2A—cerebellum—attention deficit hyperactivity disorder	0.000157	0.00163	CbGeAlD
Amitriptyline—Cyclobenzaprine—HTR2A—attention deficit hyperactivity disorder	0.000154	0.025	CrCbGaD
Amitriptyline—CYP2E1—cerebellum—attention deficit hyperactivity disorder	0.000154	0.0016	CbGeAlD
Amitriptyline—Mianserin—SLC6A3—attention deficit hyperactivity disorder	0.000154	0.025	CrCbGaD
Amitriptyline—Epinastine—HTR2A—attention deficit hyperactivity disorder	0.000153	0.0248	CrCbGaD
Amitriptyline—Cyproheptadine—DRD2—attention deficit hyperactivity disorder	0.000151	0.0245	CrCbGaD
Amitriptyline—Mianserin—ADRA2A—attention deficit hyperactivity disorder	0.000151	0.0245	CrCbGaD
Amitriptyline—Chlorprothixene—DRD3—attention deficit hyperactivity disorder	0.00015	0.0245	CrCbGaD
Amitriptyline—CYP2C8—brain—attention deficit hyperactivity disorder	0.000148	0.00154	CbGeAlD
Amitriptyline—Chlorprothixene—DRD1—attention deficit hyperactivity disorder	0.000148	0.024	CrCbGaD
Amitriptyline—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.000145	0.00151	CbGeAlD
Amitriptyline—HTR2A—nervous system—attention deficit hyperactivity disorder	0.000142	0.00148	CbGeAlD
Amitriptyline—Clomipramine—ADRA2A—attention deficit hyperactivity disorder	0.000138	0.0224	CrCbGaD
Amitriptyline—HTR2A—central nervous system—attention deficit hyperactivity disorder	0.000137	0.00142	CbGeAlD
Amitriptyline—Promazine—DRD4—attention deficit hyperactivity disorder	0.000137	0.0222	CrCbGaD
Amitriptyline—HTR2A—cerebellum—attention deficit hyperactivity disorder	0.000134	0.00139	CbGeAlD
Amitriptyline—CYP2B6—brain—attention deficit hyperactivity disorder	0.000133	0.00138	CbGeAlD
Amitriptyline—Thiothixene—DRD2—attention deficit hyperactivity disorder	0.000132	0.0215	CrCbGaD
Amitriptyline—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.000132	0.00137	CbGeAlD
Amitriptyline—HRH1—brain—attention deficit hyperactivity disorder	0.00013	0.00135	CbGeAlD
Amitriptyline—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.000129	0.00134	CbGeAlD
Amitriptyline—Trimipramine—SLC6A3—attention deficit hyperactivity disorder	0.000129	0.021	CrCbGaD
Amitriptyline—ADRA2A—brain—attention deficit hyperactivity disorder	0.000128	0.00133	CbGeAlD
Amitriptyline—Trimipramine—ADRA2A—attention deficit hyperactivity disorder	0.000127	0.0206	CrCbGaD
Amitriptyline—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.000127	0.00132	CbGeAlD
Amitriptyline—CYP2E1—brain—attention deficit hyperactivity disorder	0.000125	0.0013	CbGeAlD
Amitriptyline—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.000125	0.00129	CbGeAlD
Amitriptyline—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.000122	0.00126	CbGeAlD
Amitriptyline—Doxepin—ADRA2A—attention deficit hyperactivity disorder	0.000121	0.0196	CrCbGaD
Amitriptyline—Cyproheptadine—HTR2A—attention deficit hyperactivity disorder	0.000117	0.0189	CrCbGaD
Amitriptyline—Promazine—DRD1—attention deficit hyperactivity disorder	0.000116	0.0188	CrCbGaD
Amitriptyline—Mianserin—SLC6A4—attention deficit hyperactivity disorder	0.000115	0.0187	CrCbGaD
Amitriptyline—Mianserin—DRD2—attention deficit hyperactivity disorder	0.000114	0.0186	CrCbGaD
Amitriptyline—ABCB1—midbrain—attention deficit hyperactivity disorder	0.000113	0.00118	CbGeAlD
Amitriptyline—Desipramine—SLC6A3—attention deficit hyperactivity disorder	0.000113	0.0184	CrCbGaD
Amitriptyline—HTR2A—brain—attention deficit hyperactivity disorder	0.000109	0.00113	CbGeAlD
Amitriptyline—Promazine—ADRA2A—attention deficit hyperactivity disorder	0.000107	0.0175	CrCbGaD
Amitriptyline—Clomipramine—SLC6A4—attention deficit hyperactivity disorder	0.000105	0.0171	CrCbGaD
Amitriptyline—Chlorprothixene—DRD2—attention deficit hyperactivity disorder	0.000104	0.0169	CrCbGaD
Amitriptyline—Nortriptyline—SLC6A4—attention deficit hyperactivity disorder	0.000103	0.0167	CrCbGaD
Amitriptyline—Thiothixene—HTR2A—attention deficit hyperactivity disorder	0.000102	0.0166	CrCbGaD
Amitriptyline—Nortriptyline—DRD2—attention deficit hyperactivity disorder	0.000102	0.0166	CrCbGaD
Amitriptyline—CYP2D6—brain—attention deficit hyperactivity disorder	9.89e-05	0.00103	CbGeAlD
Amitriptyline—Trimipramine—SLC6A4—attention deficit hyperactivity disorder	9.68e-05	0.0157	CrCbGaD
Amitriptyline—Trimipramine—DRD2—attention deficit hyperactivity disorder	9.62e-05	0.0156	CrCbGaD
Amitriptyline—Imipramine—SLC6A3—attention deficit hyperactivity disorder	9.6e-05	0.0156	CrCbGaD
Amitriptyline—ABCB1—nervous system—attention deficit hyperactivity disorder	9.31e-05	0.000967	CbGeAlD
Amitriptyline—Promethazine—DRD2—attention deficit hyperactivity disorder	9.27e-05	0.0151	CrCbGaD
Amitriptyline—Doxepin—SLC6A4—attention deficit hyperactivity disorder	9.22e-05	0.015	CrCbGaD
Amitriptyline—Doxepin—DRD2—attention deficit hyperactivity disorder	9.17e-05	0.0149	CrCbGaD
Amitriptyline—ABCB1—central nervous system—attention deficit hyperactivity disorder	8.97e-05	0.000931	CbGeAlD
Amitriptyline—Mianserin—HTR2A—attention deficit hyperactivity disorder	8.84e-05	0.0144	CrCbGaD
Amitriptyline—ABCB1—cerebellum—attention deficit hyperactivity disorder	8.76e-05	0.00091	CbGeAlD
Amitriptyline—Desipramine—SLC6A4—attention deficit hyperactivity disorder	8.46e-05	0.0137	CrCbGaD
Amitriptyline—Desipramine—DRD2—attention deficit hyperactivity disorder	8.42e-05	0.0137	CrCbGaD
Amitriptyline—Promazine—DRD2—attention deficit hyperactivity disorder	8.15e-05	0.0132	CrCbGaD
Amitriptyline—Clomipramine—HTR2A—attention deficit hyperactivity disorder	8.08e-05	0.0131	CrCbGaD
Amitriptyline—Chlorprothixene—HTR2A—attention deficit hyperactivity disorder	8.05e-05	0.0131	CrCbGaD
Amitriptyline—Nortriptyline—HTR2A—attention deficit hyperactivity disorder	7.9e-05	0.0128	CrCbGaD
Amitriptyline—Trimipramine—HTR2A—attention deficit hyperactivity disorder	7.44e-05	0.0121	CrCbGaD
Amitriptyline—Imipramine—SLC6A4—attention deficit hyperactivity disorder	7.18e-05	0.0117	CrCbGaD
Amitriptyline—Promethazine—HTR2A—attention deficit hyperactivity disorder	7.16e-05	0.0116	CrCbGaD
Amitriptyline—Imipramine—DRD2—attention deficit hyperactivity disorder	7.14e-05	0.0116	CrCbGaD
Amitriptyline—ABCB1—brain—attention deficit hyperactivity disorder	7.12e-05	0.000739	CbGeAlD
Amitriptyline—Doxepin—HTR2A—attention deficit hyperactivity disorder	7.09e-05	0.0115	CrCbGaD
Amitriptyline—Desipramine—HTR2A—attention deficit hyperactivity disorder	6.5e-05	0.0106	CrCbGaD
Amitriptyline—Promazine—HTR2A—attention deficit hyperactivity disorder	6.3e-05	0.0102	CrCbGaD
Amitriptyline—Imipramine—HTR2A—attention deficit hyperactivity disorder	5.52e-05	0.00896	CrCbGaD
Amitriptyline—CYP3A5—Metabolism—CACNB2—attention deficit hyperactivity disorder	7.05e-06	4e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	7.04e-06	3.99e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—CACNA1C—attention deficit hyperactivity disorder	7.04e-06	3.99e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	7e-06	3.97e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	6.99e-06	3.97e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	6.96e-06	3.94e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—DPYD—attention deficit hyperactivity disorder	6.95e-06	3.94e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	6.94e-06	3.94e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—DPYD—attention deficit hyperactivity disorder	6.94e-06	3.93e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	6.92e-06	3.92e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	6.9e-06	3.91e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	6.83e-06	3.87e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	6.81e-06	3.86e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	6.79e-06	3.85e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	6.76e-06	3.83e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	6.7e-06	3.8e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—SNAP25—attention deficit hyperactivity disorder	6.7e-06	3.8e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	6.64e-06	3.76e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	6.6e-06	3.74e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	6.58e-06	3.73e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	6.58e-06	3.73e-05	CbGpPWpGaD
Amitriptyline—DRD2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	6.57e-06	3.72e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	6.54e-06	3.71e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	6.51e-06	3.69e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	6.47e-06	3.67e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	6.46e-06	3.66e-05	CbGpPWpGaD
Amitriptyline—HRH1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	6.45e-06	3.66e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—CACNA1C—attention deficit hyperactivity disorder	6.45e-06	3.66e-05	CbGpPWpGaD
Amitriptyline—CHRM1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	6.43e-06	3.65e-05	CbGpPWpGaD
Amitriptyline—CHRM3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	6.41e-06	3.63e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	6.38e-06	3.62e-05	CbGpPWpGaD
Amitriptyline—CHRM2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	6.35e-06	3.6e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	6.34e-06	3.59e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	6.33e-06	3.59e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	6.33e-06	3.59e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	6.3e-06	3.57e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.27e-06	3.56e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	6.23e-06	3.53e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	6.23e-06	3.53e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	6.2e-06	3.51e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	6.18e-06	3.5e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	6.15e-06	3.49e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	6.15e-06	3.49e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—SNAP25—attention deficit hyperactivity disorder	6.15e-06	3.49e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	6.12e-06	3.47e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—TPH2—attention deficit hyperactivity disorder	6.11e-06	3.46e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—CACNB2—attention deficit hyperactivity disorder	6.11e-06	3.46e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	6.08e-06	3.45e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—TPH2—attention deficit hyperactivity disorder	6.07e-06	3.44e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—CACNB2—attention deficit hyperactivity disorder	6.07e-06	3.44e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	6.07e-06	3.44e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	6.05e-06	3.43e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	6.03e-06	3.42e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	6.03e-06	3.42e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—DPYD—attention deficit hyperactivity disorder	6.01e-06	3.41e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—DPYD—attention deficit hyperactivity disorder	5.97e-06	3.39e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	5.97e-06	3.39e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	5.97e-06	3.38e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	5.95e-06	3.38e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	5.93e-06	3.36e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	5.88e-06	3.33e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	5.86e-06	3.32e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	5.86e-06	3.32e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	5.84e-06	3.31e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	5.82e-06	3.3e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—SNAP25—attention deficit hyperactivity disorder	5.77e-06	3.27e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	5.76e-06	3.27e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	5.75e-06	3.26e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	5.74e-06	3.26e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	5.73e-06	3.25e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	5.7e-06	3.23e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	5.65e-06	3.21e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—SNAP25—attention deficit hyperactivity disorder	5.65e-06	3.2e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	5.64e-06	3.2e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—SNAP25—attention deficit hyperactivity disorder	5.64e-06	3.2e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	5.62e-06	3.19e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	5.6e-06	3.18e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—CACNA1C—attention deficit hyperactivity disorder	5.58e-06	3.17e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	5.56e-06	3.15e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—CACNA1C—attention deficit hyperactivity disorder	5.55e-06	3.15e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	5.55e-06	3.15e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	5.53e-06	3.14e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	5.53e-06	3.14e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.5e-06	3.12e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	5.49e-06	3.11e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	5.47e-06	3.1e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	5.47e-06	3.1e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	5.46e-06	3.1e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	5.46e-06	3.09e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	5.45e-06	3.09e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	5.45e-06	3.09e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	5.44e-06	3.09e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	5.43e-06	3.08e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.42e-06	3.07e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.42e-06	3.07e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	5.4e-06	3.06e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.38e-06	3.05e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	5.38e-06	3.05e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	5.38e-06	3.05e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	5.37e-06	3.05e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	5.37e-06	3.04e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—ADRA2A—attention deficit hyperactivity disorder	5.36e-06	3.04e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	5.36e-06	3.04e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	5.36e-06	3.04e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	5.35e-06	3.03e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	5.34e-06	3.03e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	5.33e-06	3.03e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	5.32e-06	3.02e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	5.32e-06	3.02e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	5.31e-06	3.01e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	5.3e-06	3.01e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	5.29e-06	3e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	5.28e-06	3e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	5.27e-06	2.99e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	5.27e-06	2.99e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.27e-06	2.99e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	5.23e-06	2.97e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	5.22e-06	2.96e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	5.2e-06	2.95e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	5.14e-06	2.92e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.11e-06	2.9e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—COMT—attention deficit hyperactivity disorder	5.08e-06	2.88e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—MAOA—attention deficit hyperactivity disorder	5.04e-06	2.86e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	5.01e-06	2.84e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	5.01e-06	2.84e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	4.98e-06	2.83e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	4.98e-06	2.82e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	4.97e-06	2.82e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	4.97e-06	2.82e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	4.95e-06	2.81e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	4.94e-06	2.8e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	4.93e-06	2.8e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Hemostasis—EP300—attention deficit hyperactivity disorder	4.93e-06	2.8e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	4.92e-06	2.79e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	4.91e-06	2.78e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.9e-06	2.78e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	4.89e-06	2.77e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—SNAP25—attention deficit hyperactivity disorder	4.88e-06	2.77e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	4.87e-06	2.76e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	4.86e-06	2.76e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—SNAP25—attention deficit hyperactivity disorder	4.85e-06	2.75e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	4.85e-06	2.75e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	4.83e-06	2.74e-05	CbGpPWpGaD
Amitriptyline—HRH4—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.83e-06	2.74e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	4.75e-06	2.69e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—COMT—attention deficit hyperactivity disorder	4.66e-06	2.64e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.65e-06	2.64e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—ADRA2A—attention deficit hyperactivity disorder	4.65e-06	2.63e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—MAOA—attention deficit hyperactivity disorder	4.63e-06	2.62e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—ADRA2A—attention deficit hyperactivity disorder	4.62e-06	2.62e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.61e-06	2.61e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.61e-06	2.61e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	4.58e-06	2.6e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	4.54e-06	2.58e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	4.5e-06	2.55e-05	CbGpPWpGaD
Amitriptyline—NTRK1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.4e-06	2.5e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—COMT—attention deficit hyperactivity disorder	4.37e-06	2.48e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	4.36e-06	2.47e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—MAOA—attention deficit hyperactivity disorder	4.34e-06	2.46e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—COMT—attention deficit hyperactivity disorder	4.28e-06	2.43e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—COMT—attention deficit hyperactivity disorder	4.27e-06	2.42e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	4.25e-06	2.41e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—MAOA—attention deficit hyperactivity disorder	4.25e-06	2.41e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	4.25e-06	2.41e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	4.25e-06	2.41e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—MAOA—attention deficit hyperactivity disorder	4.24e-06	2.4e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	4.18e-06	2.37e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	4.15e-06	2.35e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	4.05e-06	2.3e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.01e-06	2.28e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	4.01e-06	2.27e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.99e-06	2.26e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	3.97e-06	2.25e-05	CbGpPWpGaD
Amitriptyline—ALB—Hemostasis—EP300—attention deficit hyperactivity disorder	3.89e-06	2.21e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	3.88e-06	2.2e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.82e-06	2.17e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	3.81e-06	2.16e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	3.78e-06	2.14e-05	CbGpPWpGaD
Amitriptyline—HRH2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.75e-06	2.12e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—COMT—attention deficit hyperactivity disorder	3.7e-06	2.1e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—COMT—attention deficit hyperactivity disorder	3.68e-06	2.09e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—MAOA—attention deficit hyperactivity disorder	3.67e-06	2.08e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—MAOA—attention deficit hyperactivity disorder	3.65e-06	2.07e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	3.56e-06	2.02e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	3.54e-06	2.01e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.52e-06	2e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.46e-06	1.96e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.45e-06	1.96e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.44e-06	1.95e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.4e-06	1.93e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.39e-06	1.93e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	3.39e-06	1.93e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.32e-06	1.88e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	3.3e-06	1.87e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	3.28e-06	1.86e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	3.28e-06	1.86e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	3.28e-06	1.86e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	3.23e-06	1.83e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	3.22e-06	1.83e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	3.22e-06	1.83e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	3.2e-06	1.81e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	3.18e-06	1.8e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.15e-06	1.79e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	3.04e-06	1.72e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	3.02e-06	1.71e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	3.01e-06	1.71e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	3e-06	1.7e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	2.99e-06	1.7e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.91e-06	1.65e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	2.9e-06	1.64e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.87e-06	1.63e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.87e-06	1.63e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.85e-06	1.62e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.79e-06	1.58e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.71e-06	1.54e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.62e-06	1.49e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.59e-06	1.47e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	2.57e-06	1.46e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	2.55e-06	1.45e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.49e-06	1.41e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	2.48e-06	1.4e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.46e-06	1.4e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.44e-06	1.38e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.44e-06	1.38e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—EP300—attention deficit hyperactivity disorder	2.18e-06	1.24e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.13e-06	1.21e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.12e-06	1.2e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.02e-06	1.15e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—EP300—attention deficit hyperactivity disorder	2e-06	1.13e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	1.99e-06	1.13e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	1.97e-06	1.12e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—EP300—attention deficit hyperactivity disorder	1.87e-06	1.06e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.87e-06	1.06e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.84e-06	1.04e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—EP300—attention deficit hyperactivity disorder	1.84e-06	1.04e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.83e-06	1.04e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—EP300—attention deficit hyperactivity disorder	1.83e-06	1.04e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.83e-06	1.04e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.82e-06	1.03e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.8e-06	1.02e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.8e-06	1.02e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.67e-06	9.48e-06	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—EP300—attention deficit hyperactivity disorder	1.59e-06	9e-06	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—EP300—attention deficit hyperactivity disorder	1.58e-06	8.94e-06	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	1.42e-06	8.03e-06	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	1.38e-06	7.84e-06	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	1.3e-06	7.39e-06	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	1.29e-06	7.32e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	1.1e-06	6.26e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	8.51e-07	4.83e-06	CbGpPWpGaD
